Effective high-dose chemotherapy combined with CD34+-selected autologous peripheral blood stem cell transplantation in a patient with cutaneous CD30-negative large T cell lymphoma

Bone Marrow Transplantation

Volumn 25, Issue 12, 2000, Pages 1315-1317

  Nishio, M ^a   Koizumi, K ^a   Endo, T ^a   Takashima, H ^a   Haseyama, Y ^a   Fujimoto, K ^a   Yamamoto, S ^a   Kobayashi, H ^a   Koike, T ^a   Sawada, K ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CD30 negative cutaneous large T cell lymphoma; CD34+ selected APBSCT; High dose chemotherapy

Indexed keywords

CARBOPLATIN; CD30 ANTIGEN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; GANCICLOVIR; IFOSFAMIDE; PIRARUBICIN; PREDNISOLONE; RANIMUSTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; ELECTRON BEAM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; SKIN TUMOR; T CELL LYMPHOMA;

EID: 0033935708     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702440     Document Type: Article

References (24)

1. Gilliam AC, Wood GS. Primary cutaneous lymphomas other than mycosis fungoides. Semin Oncol 1999; 26: 290-306.
2. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371.
3. Burg G, Kempf W, Haeffner AC et al. Cutaneous lymphomas. Curr Prob Dermatol 1997; 9: 141-203.
4. Willemze R, Beljaards RC, Rijlaarsdam U et al. Classification of primary cutaneous large cell lymphomas. Dermatol Clin 1994; 189: 361-373.
5. Brice P, Cazals D, Mounier N et al. Primary cutaneous large cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemothrapy for high-grade lymphomas. Leukemia 1998; 12: 213-219.
6. Joly P, Charlotte F, Leibowitch C et al. Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients. J Clin Oncol 1991; 11: 1994-2001.
7. Nishio M, Sawada K, Koizumi K et al. Recurrence with histological transformation 40 days after autologous peripheral blood stem cell transplantation (APBSCT) for cutaneous CD30-negative large T cell lymphoma. Bone Marrow Transplant 1998; 22: 1211-1214.
8. Tarumi T, Sawada K, Koizumi K et al. A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 1999; 34: 361-371.
9. Muche JM, Lukowsky A, Asadullah K et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T cell lymphoma. Blood 1997; 90: 1636-1642.
10. Kitamura K, Takaku F. Pirarubicin, a novel derivative of doxoruhicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly. Am J Clin Oncol 1990; 13 (Suppl 1): S15-S19.
11. Brugger W, Frisch J, Schultz, G et al. Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide and cisplatin. J Clin Oncol 1992; 9: 1452-1459.
12. + cells. Use of immunomagnetic microspheres. Bone Marrow Transplant 1997; 19: 373-379.
13. + cells using nylon-fiber syringe system and immunomagnetic microspheres. Cytotherapy 1999; 1: 319-327.
14. Koizumi K, Sawada K, Nishio M et al. Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis. Bone Marrow Transplant 1997; 20: 171-173.
15. Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigenemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994; 86: 130-137.
16. Willemze R, Meijer CJLM, Sentis HJ et al. Primary cutaneous large cell lymphoma of follicle center origin. Am Acad Dermatol 1987; 16: 518-524.
17. de Bruin PC, Beljaards RC, van Heerde P et al. Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T cell or null phenotype. Histopathol 1993; 23: 127-132.
18. Harris N, Jeffe E, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
19. Phillipe A, Lepagney ML, Bureau B et al. Primary cutaneous lymphomas: a study of 37 cases. Int J Dermatol 1997; 36: 582-586.
20. Beljaards RC, Chris JL, Meijer M et al. Primary cutaneous T cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. J Pathol 1994; 172: 53-60.
21. +-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-center experience. Bone Marrow Transplant 1997; 20: 827-834.
22. +-selected autologous peripheral blood stem cell transplantation in a patient with subcutaneous panniculitic T cell lymphoma (SPTCL) transformed into leukemia. Bone Marrow Transplant 1999; 24: 1369-1371.
23. Weiner RS, Bortin MM, Gale RP et al. Interstitial pneumonitis after bone marrow transplantation. Ann Intern Med 1986; 104: 168-175.
24. Pecego R, Hill R, Applebaum FR et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986; 42: 515-517.